Nompharma’s mission is to deliver the right medicine to the right patient at the right time.We are responsible to the society. We shall be good corporate citizens and will be driven by high ethical standards in our practices.
We provide access to our own and other pharmaceutical companies' products, whether to meet unmet medical needs or for use in clinical trials. This includes providing access to medicines that have received regulatory approval, but may not be available in a specific patient’s own country (‘unlicensed’ medicines). Ethical unlicensed access helps protect patients from the growing threat of counterfeit medicines distributed online.
Nompharma is dedicated to providing an ethical and compliant route for healthcare professionals to source medicines.
Whether a medicine is unlicensed in a given country, not yet commercially available, is experiencing a supply disruption, or is discontinued, we can help. Our expertise in this area extends not just across the entire commercial lifecycle of a product, but to pre- and post-commercial stages too.
The patient is central to everything we do day-to-day. Often if they are using one of our niche or unlicensed medicines it is because they have failed to respond to front line therapies or have a rare or difficult to treat condition. Shortages and delays can be life-threatening. In a similar way, if a comparator medicine is unavailable for a clinical trial, progress in developing new treatments can be significantly delayed. We don’t just help make medicines available, we get them to the people who need them. All over the world and however challenging the circumstances.
Our vision is to be one of the leading wholesale pharmaceutical companies in the UK and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment.